BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 24439053)

  • 1. Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.
    Shakshouk H; Tkaczyk ER; Cowen EW; El-Azhary RA; Hashmi SK; Kenderian SJ; Lehman JS
    Transplant Cell Ther; 2021 Sep; 27(9):738-746. PubMed ID: 34107339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia.
    Kovalszki A; Weller PF
    Prim Care; 2016 Dec; 43(4):607-617. PubMed ID: 27866580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
    Ahmad I; Labbé AC; Chagnon M; Busque L; Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Roy J
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1673-8. PubMed ID: 21601640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Mortensen KB; Gerds TA; Bjerrum OW; Lindmark A; Sengeløv H; Andersen CL
    Leuk Res; 2014 Mar; 38(3):334-9. PubMed ID: 24439053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case.
    Ganta CC; Chatterjee S; Pohlman B; Hojjati M
    J Clin Rheumatol; 2015 Mar; 21(2):86-94. PubMed ID: 25710860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.
    Hull K; Kerridge I; Avery S; McCullough M; Ritchie D; Szer J
    Intern Med J; 2015 Jul; 45(7):702-10. PubMed ID: 26134695
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.